Eleven telomere, epigenetic clock, and biomarker-composite quantifications of biological aging: do they measure the same thing?

DW Belsky, TE Moffitt, AA Cohen… - American journal of …, 2018 - academic.oup.com
The geroscience hypothesis posits that therapies to slow biological processes of aging can
prevent disease and extend healthy years of life. To test such “geroprotective” therapies in …
被引用次数：365 相关文章

Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging: Do They Measure the Same Thing?

DW Belsky, TE Moffitt, AA Cohen… - American Journal of …, 2018 - search.ebscohost.com
The geroscience hypothesis posits that therapies to slow biological processes of aging can
prevent disease and extend healthy years of life. To test such" geroprotective" therapies in …

Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging: Do They Measure the Same Thing?

DW Belsky, TE Moffitt, AA Cohen… - American journal of …, 2018 - experts.umn.edu
The geroscience hypothesis posits that therapies to slow biological processes of aging can
prevent disease and extend healthy years of life. To test such" geroprotective" therapies in …
[PDF] duke.edu

[PDF][PDF] Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging: Do They Measure the Same Thing?

DW Belsky, TE Moffitt, AA Cohen, DL Corcoran… - 2018 - moffittcaspi.trinity.duke.edu
The geroscience hypothesis posits that therapies to slow biological processes of aging can
prevent disease and extend healthy years of life. To test such “geroprotective” therapies in …

Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging: Do They Measure the Same Thing?

DW Belsky, TE Moffitt, AA Cohen… - American journal …, 2018 - pubmed.ncbi.nlm.nih.gov
The geroscience hypothesis posits that therapies to slow biological processes of aging can
prevent disease and extend healthy years of life. To test such" geroprotective" therapies in …
[HTML] nih.gov

[HTML][HTML] Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging: Do They Measure the Same Thing?

DW Belsky, TE Moffitt, AA Cohen… - American Journal of …, 2018 - ncbi.nlm.nih.gov
The geroscience hypothesis posits that therapies to slow biological processes of aging can
prevent disease and extend healthy years of life. To test such “geroprotective” therapies in …

Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging:: Do They Measure the Same Thing?

DW Belsky, TE Moffitt, AA Cohen… - American Journal of …, 2018 - kclpure.kcl.ac.uk
The geroscience hypothesis posits that therapies to slow biological processes of aging can
prevent disease and extend healthy years of life. To test such “gero-protective” therapies in …

Eleven Telomere, Epigenetic Clock, and Biomarker-Composite Quantifications of Biological Aging: Do They Measure the Same Thing?

DW Belsky, TE Moffitt, AA Cohen… - American Journal of …, 2018 - academic.oup.com
The geroscience hypothesis posits that therapies to slow biological processes of aging can
prevent disease and extend healthy years of life. To test such “geroprotective” therapies in …

Eleven telomere, epigenetic clock, and biomarker-composite quantifications of biological aging: do they measure the same thing?

DW Belsky, TE Moffitt, AA Cohen, DL Corcoran… - 2018 - cabidigitallibrary.org
The geroscience hypothesis posits that therapies to slow biological processes of aging can
prevent disease and extend healthy years of life. To test such" geroprotective" therapies in …

Telomere, epigenetic clock, and biomarker-composite quantifications of biological aging: Do they measure the same thing?

DW Belsky, TE Moffitt, AA Cohen, D Corcoran… - bioRxiv, 2016 - biorxiv.org
The geroscience hypothesis posits that therapies to retard biological processes of aging can
prevent disease. To test such “geroprotective” therapies in humans, surrogate endpoints are …